Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 4:15:35.
doi: 10.1186/s12986-018-0269-8. eCollection 2018.

Cold-pressed minke whale oil reduces circulating LDL/VLDL-cholesterol, lipid oxidation and atherogenesis in apolipoprotein E-deficient mice fed a Western-type diet for 13 weeks

Affiliations

Cold-pressed minke whale oil reduces circulating LDL/VLDL-cholesterol, lipid oxidation and atherogenesis in apolipoprotein E-deficient mice fed a Western-type diet for 13 weeks

Mari Johannessen Walquist et al. Nutr Metab (Lond). .

Abstract

Background: Long-chain n3-polyunsaturated fatty acids (LC n3-PUFA) are well known for their anti-inflammatory activity and their impact on cardiovascular disease. Cold-pressed whale oil (CWO) has half the amount of LC n3-PUFA compared to cod liver oil (CLO). Still, there has been observed more pronounced beneficial effects on cardiovascular disease markers from intake of CWO compared to intake of CLO in human intervention studies. Extracts from CWO deprived of fatty acids have also been shown to display antioxidative and anti-inflammatory effects in vitro. The aim of this study was to investigate whether intake of a high-fat Western-type diet (WD) supplemented with CWO would prevent the development of atherosclerotic lesions in apolipoprotein E-deficient (ApoE-/-) mice.

Methods: Seventy female ApoE-/- mice were fed a WD containing 1% CWO, CLO or corn oil (CO). Atherosclerotic lesion formation, body and tissue weights, hepatic gene expression together with serum levels of LDL/VLDL-cholesterol, ox-LDL, total antioxidant status and various serum cardiovascular disease/proinflammatory markers were evaluated. Statistical analyses were performed using SPSS, and Shapiro-Wilk's test was performed to determine the distribution of the variables. Statistical difference was assessed using One-Way ANOVA with Tukeys' post hoc test or Kruskal-Wallis test. The hepatic relative gene expression was analysed with REST 2009 (V2.0.13).

Results: Mice fed CWO had less atherosclerotic lesions in the aortic arch compared to mice fed CO. Levels of LDL/VLDL-cholesterol and ox-LDL-cholesterol were also markedly reduced whereas total antioxidant levels were enhanced in mice fed CWO compared to CO-fed mice. In addition, CWO-fed mice gained less weight and several hepatic genes involved in the cholesterol metabolism were up-regulated compared to CO-fed mice.

Conclusion: In the present study mice fed a WD supplemented with 1% CWO had reduced formation of atherosclerotic lesions in the aortic arch, reduced serum LDL/VLDL-cholesterol and ox-LDL-cholesterol, increased serum total antioxidant status and reduced body weight compared to mice fed a WD supplemented with 1% CO.

Keywords: Atherosclerosis; Balaenoptera acutorostrata; Blubber; Gene expression; LDL-cholesterol; Lesions; Plaque; VLDL-cholesterol; Whale oil.

PubMed Disclaimer

Conflict of interest statement

The Norwegian Animal Research Authority approved the study (approval number 3828). All experiments were performed following Federation for Laboratory Animal Science Association recommendations and according to the Norwegian legislation on the care and use of experimental animals.The authors declare no competing interests, neither financial nor non-financial.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Average daily feed intake (g/mice) of female apolipoprotein E-deficient mice fed high-fat diets supplemented with different oils for 13 weeks. The results are presented as mean ± SD. CO (n = 11), CLO (n = 12), RWO (n = 12), RWO-I (n = 11), RWO-II (n = 12), CWO (n = 11)
Fig. 2
Fig. 2
Final body weight (a), liver weight (b) and growth curves (c) of female apolipoprotein E-deficient mice fed high-fat diets supplemented with difference oils for 13 weeks. Data are presented as box plots representing a 95% confidence interval (CI) for the median (a and b) and as bars representing mean ± SD (c). a denotes significant different from CO (diet A), p < 0.05. CO (n = 11), CLO (n = 9), RWO (n = 11), RWO-I (n = 11), RWO-II (n = 12), CWO (n = 10)
Fig. 3
Fig. 3
Box plot of atherosclerotic plaque burden expressed as aortic area percentage covered by lipid Oil Red O staining in female apolipoprotein E-deficient mice fed high-fat diets supplemented with different oils for 13 weeks (a-d). Data are presented as a 95% confidence interval (CI) for the median, and a denotes significant difference from mice fed CO (diet A) with p < 0.05. CO (n = 11), CLO (n = 9), RWO (n = 11), RWO-I (n = 11), RWO-II (n = 12), CWO (n = 10). (e) shows a representative aorta from each group stained with Oil Red O Staining
Fig. 4
Fig. 4
Box plot of serum total antioxidant status (a), LDL/VLDL-cholesterol levels (b), ox-LDL-cholesterol levels (c) and total cholesterol (d) in female apolipoprotein E-deficient mice fed high-fat diets supplemented with different oils for 13 weeks. Data are presented with 95% confidence interval (CI), and a denotes significant different from mice fed CO (diet A) whereas b denotes significant difference from mice fed CLO (diet B) with p < 0.05. CO (n = 11), CLO (n = 9), RWO (n = 11), RWO-I (n = 11), RWO-II (n = 12), CWO (n = 10)

References

    1. Boudoulas KD, et al. Coronary atherosclerosis: pathophysiologic basis for diagnosis and management. Prog Cardiovasc Dis. 2016;58(6):676–692. doi: 10.1016/j.pcad.2016.04.003. - DOI - PubMed
    1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–325. doi: 10.1038/nature10146. - DOI - PubMed
    1. Khan R, et al. Novel anti-inflammatory therapies for the treatment of atherosclerosis. Atherosclerosis. 2015;240(2):497–509. doi: 10.1016/j.atherosclerosis.2015.04.783. - DOI - PubMed
    1. Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999;340(2):115–126. doi: 10.1056/NEJM199901143400207. - DOI - PubMed
    1. Tabas I, García-Cardeña G, Owens GK. Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015;209(1):13–22. doi: 10.1083/jcb.201412052. - DOI - PMC - PubMed

LinkOut - more resources